46 results on '"Cruz, Charles S. Dela"'
Search Results
2. Developmental changes in lung function of mice are independent of sex as a biological variable.
3. Anti-inflammatory roles of type I interferon signaling in the lung.
4. Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma
5. Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19.
6. Author Correction: Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity
7. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report.
8. ProtAnno, an Automated Cell Type Annotation Tool for Single Cell Proteomics Data that integrates information from Multiple Reference Sources
9. Additional file 2 of Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma
10. Additional file 1 of JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis
11. PD-1highCXCR5–CD4+ Peripheral Helper T (Tph) cells Promote Tissue-Homing Plasmablasts in COVID-19
12. Emerging insights in sarcoidosis: moving forward through reverse translational research.
13. Cigarette smoke selectively enhances viral PAMP--and virus-induced pulmonary innate immune and remodeling responses in mice
14. Author Correction: Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity
15. Single-cell Profiling of the Response to Poly I:C in Peripheral Blood Mononuclear Cells in Severe Asthma
16. COVID-19: How Do We Stay Safe?
17. JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis
18. Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection
19. The Kinetics of Humoral Response and its Relationship with the Disease Severity in COVID-19
20. Diagnosis and Management of COVID-19 Disease
21. Social Distancing and Personal Protective Measures Decrease Influenza Morbidity and Mortality
22. Single Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis
23. Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline.
24. Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva.
25. Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19.
26. Disinfection of Pseudomonas aeruginosa from N95 respirators with ozone: a pilot study.
27. Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.
28. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).
29. High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis
30. Adding Insult to Injury - Does COVID-19 Promote ARDS by Inhibiting Surfactant?
31. MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury
32. Pneumococcal Vaccination Strategies. An Update and Perspective.
33. Role of Breast Regression Protein–39 in the Pathogenesis of Cigarette Smoke–Induced Inflammation and Emphysema
34. Chitinase 3-like-1 Regulates Both Visceral Fat Accumulation and Asthma-like Th2 Inflammation.
35. CCL9 Is Secreted by the Follicle-Associated Epithelium and Recruits Dome Region Peyer’s Patch CD11b+ Dendritic Cells
36. Breakdown of CTL Tolerance to Self HLA-B*2705 Induced by Exposure toChlamydia trachomatis
37. Letter to the Editor: Concerning the Anti-Major Histocompatibility Complex Approach to HIV Type 1 Vaccine Design
38. Novel Wuhan (2019-nCoV) Coronavirus.
39. Vaping-associated Pulmonary Illness (VAPI).
40. Reply to Suri et al.
41. Volcanic Eruptions and Threats to Respiratory Health.
42. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
43. Damage sensing through TLR9 Promotes Viral Clearance and Recovery During Influenza Infection.
44. Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection.
45. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators.
46. Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.